Daptomycin and combination daptomycin-ceftaroline as salvage therapy for persistent methicillin-resistant Staphylococcus aureus bacteremia

被引：26

作者：

Cortes-Penfield, Nicolas ^{[1
]}

Oliver, Nora T. ^{[2
,3
]}

Hunter, Andrew ^{[4
]}

Rodriguez-Barradas, Maria ^{[1
,4
]}

机构：

[1] Baylor Coll Med, Dept Med, Infect Dis Sect, Houston, TX 77030 USA

[2] Atlanta VA Med Ctr, Infect Dis Sect, Atlanta, GA USA

[3] Emory Univ, Div Infect Dis, Sch Med, Atlanta, GA USA

[4] Michael E DeBakey VA Med Ctr, Infect Dis Sect, Med Care Line, Houston, TX USA

来源：

INFECTIOUS DISEASES | 2018年 / 50卷 / 08期

基金：

美国国家卫生研究院;

关键词：

PHARMACOKINETIC/PHARMACODYNAMIC MODEL; IN-VITRO; VANCOMYCIN; MRSA;

D O I：

10.1080/23744235.2018.1448110

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：643 / 647

页数：5

共 9 条

[1] Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model [J].

Barber, Katie E. ;

Smith, Jordan R. ;

Ireland, Cortney E. ;

Boles, Blaise R. ;

Rose, Warren E. ;

Rybak, Michael J. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) :4497-4503

[2] Observation of "Seesaw Effect" with Vancomycin, Teicoplanin, Daptomycin and Ceftaroline in 150 Unique MRSA Strains [J].

Barber K.E. ;

Ireland C.E. ;

Bukavyn N. ;

Rybak M.J. .

Infectious Diseases and Therapy, 2014, 3 (1) :35-43

[3] Daptomycin non-susceptible, vancomycin-intermediate Staphylococcus aureus endocarditis treated with ceftaroline and daptomycin: case report and brief review of the literature [J].

Baxi, Sanjiv M. ;

Chan, Dominic ;

Jain, Vivek .

INFECTION, 2015, 43 (06) :751-754

[4] Combination of Vancomycin and β-Lactam Therapy for Methicillin-Resistant Staphylococcus aureus Bacteremia: A Pilot Multicenter Randomized Controlled Trial [J].

Davis, Joshua S. ;

Sud, Archana ;

O'Sullivan, Matthew V. N. ;

Robinson, James O. ;

Ferguson, Patricia E. ;

Foo, Hong ;

van Hal, Sebastiaan J. ;

Ralph, Anna P. ;

Howden, Benjamin P. ;

Binks, Paula M. ;

Kirby, Adrienne ;

Tong, Steven Y. C. .

CLINICAL INFECTIOUS DISEASES, 2016, 62 (02) :173-180

[5] Association Between Vancomycin Minimum Inhibitory Concentration and Mortality Among Patients With Staphylococcus aureus Bloodstream Infections A Systematic Review and Meta-analysis [J].

Kalil, Andre C. ;

Van Schooneveld, Trevor C. ;

Fey, Paul D. ;

Rupp, Mark E. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 312 (15) :1552-1564

[6]

Nigo M, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01235-16, 10.1128/aac.01235-16]

[7]

Ok HS, 2013, KOREAN J INTERN MED, V28, P678

[8] A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA) [J].

Shafiq, Iffat ;

Bulman, Zackery P. ;

Spitznogle, Sarah L. ;

Osorio, Justin E. ;

Reilly, Irene S. ;

Lesse, Alan J. ;

Parameswaran, Ganapathi I. ;

Mergenhagen, Kari A. ;

Tsuji, Brian T. .

INFECTIOUS DISEASES, 2017, 49 (05) :410-416

[9] Ceftaroline Increases Membrane Binding and Enhances the Activity of Daptomycin against Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus in a Pharmacokinetic/Pharmacodynamic Model [J].

Werth, Brian J. ;

Sakoulas, George ;

Rose, Warren E. ;

Pogliano, Joseph ;

Tewhey, Ryan ;

Rybak, Michael J. .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) :66-73

← 1 →